... include chemotherapy, immunomodulatory drugs, corticosteroids, histone deacetylase (HDAC) inhibitors, monoclonal antibodies, proteasome inhibitors, and bisphosphonates.ChemotherapyChemotherapy is the treatment of cancer with drugs that destroy or slow the growth of cancer cells.Chemotherapy drugs include: Adriamycin (doxorubicin) Alkeran (melphalan) Cytoxan ...
... include chemotherapy, immunomodulatory drugs, corticosteroids, histone deacetylase (HDAC) inhibitors, monoclonal antibodies, proteasome inhibitors, and bisphosphonates.ChemotherapyChemotherapy is the treatment of cancer with drugs that destroy or slow the growth of cancer cells.Chemotherapy drugs include: Adriamycin (doxorubicin) Alkeran (melphalan) Cytoxan ...
... Treating Abnormal Plasma Cells in Amyloidosis and MyelomaDoctors recommend using chemotherapy drugs, such as cyclophosphamide (Cytoxan), to treat both conditions. Chemotherapy drugs are often paired with targeted therapy medications, which attack specific molecules found on plasma cells. ...
... Treating Abnormal Plasma Cells in Amyloidosis and MyelomaDoctors recommend using chemotherapy drugs, such as cyclophosphamide (Cytoxan), to treat both conditions. Chemotherapy drugs are often paired with targeted therapy medications, which attack specific molecules found on plasma cells. ...
... Such drugs include proteasome inhibitors — carfilzomib (Kyprolis), bortezomib (Velcade), and ixazomib (Ninlaro) and alkylating agents — cyclophosphamide (Cytoxan), melphalan (Alkeran), and bendamustine (Treanda).Radiation TherapyAs with chemotherapy, radiation therapy (also called radiotherapy) can increase a person’s risk of developing infections due ...
... Such drugs include proteasome inhibitors — carfilzomib (Kyprolis), bortezomib (Velcade), and ixazomib (Ninlaro) and alkylating agents — cyclophosphamide (Cytoxan), melphalan (Alkeran), and bendamustine (Treanda).Radiation TherapyAs with chemotherapy, radiation therapy (also called radiotherapy) can increase a person’s risk of developing infections due ...
... Alkylating agents approved to treat multiple myeloma include: Melphalan (Alkeran) Carmustine (BiCNU) Cyclophosphamide (Cytoxan) Vincristine (formerly sold as Oncovin) Melphalan flufenamide (Pepaxto) Bendamustine (Treanda) AnthracyclinesChemotherapy drugs called anthracyclines also damage DNA and prevent cells from dividing. ...
... Alkylating agents approved to treat multiple myeloma include: Melphalan (Alkeran) Carmustine (BiCNU) Cyclophosphamide (Cytoxan) Vincristine (formerly sold as Oncovin) Melphalan flufenamide (Pepaxto) Bendamustine (Treanda) AnthracyclinesChemotherapy drugs called anthracyclines also damage DNA and prevent cells from dividing. ...
... He treated me very aggressively with four chemo drugs, Adriamyacin, Cytoxan, Vincristine, and Methotrexate, along with steroids and Thalidomide up to the highest dosage. I went into the hospital for a week and got that poison. ...
... He treated me very aggressively with four chemo drugs, Adriamyacin, Cytoxan, Vincristine, and Methotrexate, along with steroids and Thalidomide up to the highest dosage. I went into the hospital for a week and got that poison. ...